Dr. Weyand shares her expertise regarding key facts in diagnosing and managing VWD. She also explains why VWD is frequently misdiagnosed and what frontline physicians should be aware of.

Dr. O’Brien answers questions regarding the treatment of pediatric and young adult patients living with von Willebrand disease and describes the role of prophylaxis in this population of patients.

In this activity, Dr. O’Brien clarifies the role of the frontline physician in the initial diagnosis, management, and subsequent follow-up of patients living with VWD.

In this activity, Dr. Escobar describes how to individualize therapy, such as how to tailor replacement therapy for patients regardless of VWD phenotype.

In this activity, Dr. Miguel Escobar describes why women with VWD often escape detection until a crisis and what symptoms should prompt clinicians to dig deeper.